Status:
COMPLETED
Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Breast Cancer Research Foundation
Conditions:
Breast Cancer
Neuropathy
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
This study seeks to determine if 12 weeks of weekly electro-acupuncture will prevent or decrease neuropathic pain in breast cancer patients receiving 12 weekly treatments of taxane treatment.
Detailed Description
Chemotherapy induced neuropathy (CIN) is a common and disabling toxicity of cytotoxic chemotherapy. Depending on the drug, it is often irreversible even after the offending agent is removed. The conse...
Eligibility Criteria
Inclusion
- Age\>21 years
- History of stage I-III breast cancer
- Patient scheduled to be receiving weekly adjuvant or neo-adjuvant paclitaxel for 12 weeks
- Signed informed consent
Exclusion
- Previous treatment with acupuncture in the last 12 months
- Diabetic Neuropathy or other neurological conditions
- Inflammatory, metabolic or neuropathic arthropathies
- Current narcotic use
- Severe concomitant illnesses
- Severe coagulopathy or bleeding disorder
- Dermatological disease within the acupuncture area
- Have a pacemaker
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01163682
Start Date
December 1 2010
End Date
May 1 2017
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032